TNL Mediagene announced a 1-for-8 share consolidation (reverse stock split) effective September 8, 2026, to regain compliance with Nasdaq's minimum bid price requirement and enhance attractiveness to institutional investors. The Board approved the ratio on August 27, 2026, following shareholder authorization in August 2026. Outstanding shares will decrease from approximately 6,084,581 to roughly 760,573, with fractional shares rounded up. This corporate action is material as it addresses listing compliance risks and significantly alters the capital structure. TNL Mediagene operates in the technology and digital media industry, providing AI-driven advertising, marketing technology, content commerce, and data analytics solutions across Asia.

On August 23, 2026, the Nasdaq Hearings Panel granted TNL Mediagene’s request for continued listing on The Nasdaq Capital Market, reversing a June 22 deletermination notice. The Company must demonstrate compliance with Listing Rule 5550(a)(2) (Bid Price Rule) by September 21, 2026, and Listing Rule 5550(b)(1) (Equity Rule) by October 30, 2026. Failure to meet these conditions will result in delisting from Nasdaq under the symbol TNMG. TNL Mediagene operates as a technology and digital media company providing AI-driven advertising, marketing technology, content commerce, and data analytics solutions across Asia.

TNL Mediagene received a Nasdaq staff determination letter on June 22, 2026, notifying the company's securities are subject to delisting from the Nasdaq Capital Market. The delisting notice is based on the company's closing bid price falling below $1.00 for 30 consecutive business days and failure to comply with the $2,500,000 minimum stockholders' equity requirement. The company intends to appeal via a hearing before a Nasdaq Hearings Panel to present a plan to regain compliance. TNL Mediagene is a media and entertainment company based in Japan and Taiwan.

TNL Mediagene is filing this 6-K to disclose the home country rule exemption from certain Nasdaq Rules regarding shareholder approval for specific types of securities issuances. The Company is electing to follow the own practices of its home country, following Nasdaq Rule 5615(a)(3). pursuant to the home country rule exemption.